Sort   by:  
 Page size 
UnknownMental-physical multimorbidity treatment adherence challenges in Brazilian primary care: A qualitative study with patients and their healthcare providers.
Not available
S-EPMC8118469 | biostudies-literature
UnknownEfficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriers.
Not available
S-EPMC7485993 | biostudies-literature
UnknownEstrogenicity of chemical mixtures revealed by a panel of bioassays.
Not available
S-EPMC8210648 | biostudies-literature
UnknownA deep look into the storm: Israeli multi-center experience of coronavirus disease 2019 (COVID-19) in patients with autoimmune inflammatory rheumatic diseases before and after vaccinations.
Not available
S-EPMC10040776 | biostudies-literature
UnknownLGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma.
Not available
S-EPMC7612792 | biostudies-literature
UnknownA global reference for caesarean section rates (C-Model): a multicountry cross-sectional study.
Not available
S-EPMC4873961 | biostudies-literature
UnknownACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis.
Not available
S-EPMC7093969 | biostudies-literature
UnknownPhenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis.
Not available
S-EPMC6771590 | biostudies-literature
UnknownContinuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y).
Not available
S-EPMC8292566 | biostudies-literature
UnknownGastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort.
Not available
S-EPMC12695048 | biostudies-literature
Sort   by:  
 Page size